Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bibby

Showing results (91-100 of 204) with videos related to

Pageof 21
Sort By:
Oncology Reports|September 6, 2005
Expression of HIF-1alpha and Glut-1 in human bladder cancerV Palit, R M Phillips, R Puri, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 1, 1996
Potentiation of testicular cytotoxicity by the alkyltransferase inhibitor O6 benzylguanine and the 5-fluorouracil/N-(2-chloroethyl)-N-nitrosourea molecular combination, B.4152M J Thompson, S Abdhul-Rahmann, T G Baker, et al.
Breast Cancer Research and Treatment|May 1, 1997
Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude miceR J Hambly, J A Double, M J Thompson, et al.
Investigational New Drugs|August 1, 1992
Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse modelP M Loadman, M C Bibby, J A Double, et al.
Journal of Chromatography. B, Biomedical Applications|October 20, 1995
Extraction of the synthetic lytic peptide, cecropin B, from biological fluid and analysis using reversed-phase high-performance liquid chromatographyA J Moore, P M Loadman, D A Devine, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrationsJ A Double, M C Bibby, P M Loadman, et al.
British Journal of Cancer|February 1, 1987
Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid)M C Bibby, J A Double, R M Phillips, et al.
Anticancer Research|July 11, 2006
Reducing the cost of screening novel agents using the hollow fibre assayS D Shnyder, P A Cooper, A J Scally, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Potentiation of EO9 anti-tumour activity by hydralazineM C Bibby, N R Sleigh, P M Loadman, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1996
Antimicrobial activity of cecropinsA J Moore, W D Beazley, M C Bibby, et al.
Pageof 21

Showing results (91-100 of 204) with videos related to

Sort By:
Pageof 21
Oncology Reports|September 6, 2005
Expression of HIF-1alpha and Glut-1 in human bladder cancerV Palit, R M Phillips, R Puri, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 1, 1996
Potentiation of testicular cytotoxicity by the alkyltransferase inhibitor O6 benzylguanine and the 5-fluorouracil/N-(2-chloroethyl)-N-nitrosourea molecular combination, B.4152M J Thompson, S Abdhul-Rahmann, T G Baker, et al.
Breast Cancer Research and Treatment|May 1, 1997
Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude miceR J Hambly, J A Double, M J Thompson, et al.
Investigational New Drugs|August 1, 1992
Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse modelP M Loadman, M C Bibby, J A Double, et al.
Journal of Chromatography. B, Biomedical Applications|October 20, 1995
Extraction of the synthetic lytic peptide, cecropin B, from biological fluid and analysis using reversed-phase high-performance liquid chromatographyA J Moore, P M Loadman, D A Devine, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrationsJ A Double, M C Bibby, P M Loadman, et al.
British Journal of Cancer|February 1, 1987
Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid)M C Bibby, J A Double, R M Phillips, et al.
Anticancer Research|July 11, 2006
Reducing the cost of screening novel agents using the hollow fibre assayS D Shnyder, P A Cooper, A J Scally, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Potentiation of EO9 anti-tumour activity by hydralazineM C Bibby, N R Sleigh, P M Loadman, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1996
Antimicrobial activity of cecropinsA J Moore, W D Beazley, M C Bibby, et al.
Pageof 21